Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K083114
    Date Cleared
    2009-03-31

    (161 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Acuson P50 Ultrasound System is intended for diagnostic ultrasound imaging or fluid flow analysis of the human body. The system includes the AcuNav 10F and 8F transducers which are intended for intra-cardiac and intra-luminal visualization of the cardiac and great vessel anatomy and physiology as well as the visualization of other devices in the heart of adult and pediatric patients. The system also includes the SieClear application. SieClear improves contrast resolution when using linear-type transducers by interrogating the target tissue from different imaging angles and adding these images together to create a composite image. This is performed in real-time.

    Device Description

    The Siemens Acuson P50 system has been designed to meet the following product safety standards: UL 60601-1, Safety Requirements for Medical Equipment; IEC 60601-2-37 Diagnostic Ultrasound Safety Standards; CSA C22.2 No. 601-1, Safety Requirements for Medical Equipment; AIUM/NEMA UD-3, 1998 Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment; AIUM/NEMA UD-2, 1998 Acoustic Output Measurement Standard for Diagnostic Ultrasound; 93/42/EEC Medical Devices Directive; Safety and EMC Requirements for Medical Equipment; EN/IEC 60601-1; EN/IEC 60601-1-1; EN/IEC 60601-1-2; IEC 1157 Declaration of Acoustic Power; ISO 10993-1 Biocompatibility.

    AI/ML Overview

    The provided text describes the Siemens Acuson P50 Ultrasound System. However, it does not include specific acceptance criteria or an explicit study proving the device meets performance criteria as typically found in a clinical performance study. Instead, it details regulatory compliance, predicate device information, and a summary of the system's intended use and technical features.

    The "Performance Data" section ([1]E. Performance Data) simply states: "The P50 modifications are verified and validated according to the company's design control process." This is a general statement about internal quality processes, not a report of a specific study with defined acceptance criteria and results.

    Therefore, many of the requested details cannot be extracted from the provided document.

    Here's a breakdown of what can be extracted and what cannot:

    1. Table of Acceptance Criteria and Reported Device Performance:

    Acceptance CriteriaReported Device Performance
    Not specified in the document. The document states "The P50 modifications are verified and validated according to the company's design control process," but does not list specific performance metrics or thresholds.Not specified in the document. No quantitative performance data (e.g., sensitivity, specificity, accuracy, image quality scores) is provided that could be compared against acceptance criteria.

    2. Sample size used for the test set and the data provenance:

    • Sample Size: Not specified.
    • Data Provenance: Not specified.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Number of Experts: Not specified.
    • Qualifications of Experts: Not specified.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

    • Adjudication Method: Not specified.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • MRMC Study: Not mentioned or indicated. The document focuses on the ultrasound system and its transducers, not on AI-assisted interpretation.
    • Effect size: Not applicable as no such study is presented.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Standalone Performance Study: Not mentioned or indicated.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    • Type of Ground Truth: Not specified.

    8. The sample size for the training set:

    • Sample Size: Not specified.

    9. How the ground truth for the training set was established:

    • Ground Truth Establishment: Not specified.

    In summary, the provided submission focuses on regulatory compliance, outlining the device's technical specifications, intended uses, and substantial equivalence to a predicate device, rather than providing detailed clinical performance study results with acceptance criteria. The "Performance Data" section is a general statement about internal validation processes, not a report of specific study findings.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1